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Abstract
Films, fibers, sponges and disks, based on poly(ε-caprolactone), PCL were
prepared using solvent-casting, electrospinning, supercritical fluid processing
and melt-compression, respectively. The extent of degradation was deter-
mined by measuring the change in morphology, crystallinity and molecular
weight (MW). The influence of processing method, MW and drug presence
on degradation rate was also evaluated. The different processing techniques
produced samples of various morphology and crystallinity. Nevertheless, the
differences in degradation rate were not so significant during the advanced
stage (18 to 36 months), while some differences existed during the initial
stage (up to 18 months). MW had an important effect on degradation rate,
while drug did not. The low MW disks had a degradation rate that was lower
by one order of magnitude than high MW constructs.
Keywords: poly(ε-caprolactone), hydrolytic degradation, solvent-casting,
melt compression, electrospinning, supercritical fluid
1. Introduction
Solvent-casting, melt compression, supercritical fluid (SCF) processing
and electrospinning are well known techniques to produce materials for tis-
sue engineering and controlled drug delivery (CDDS) applications [1, 2, 3, 4].
Poly(ε-caprolactone), PCL and other polyesters are usually the materials of
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choice for the preparation of scaffolds for tissue engineering applications and
of implants/matrices for CDDS applications [5]. These polymers are com-
mercially available, inexpensive, biocompatible and biodegradable (which en-
sures scaffold/implant integration at the site of implantation). Moreover,
they can be easily processed using diverse techniques, that allow control of
scaffold/implant morphology and/or control of drug loading and distribution
and subsequently release profile.
Degradation profile has to be carefully controlled because it will directly
influence the in vivo performance of the scaffold or CDDS. Usually, dur-
ing degradation several simultaneous physical (water uptake, dissolution)
and chemical phenomena (thermolysis, oxidation, hydrolysis) take place that
will lead to a change in material properties and induce a certain in vivo
response. For a scaffold, the degradation period of the polymer has to be
manipulated in a such a way that the scaffold ensures mechanical support to
three-dimensional tissue formation and then it gradually disappears in order
to integrate the new tissue at the implantation site. For a CDDS, the degra-
dation period has to match the drug release period and it can also determine
the release profile [5].
Several factors that influence the degradation process of polyesters were
studied such as polymer chemical stability, polymer molecular weight (MW),
sample size and geometry, surface-to-volume ratio, degradation medium (type,
temperature and pH), blending, end-group chemistry, hydrophilicity, crys-
tallinity, drug presence, drug loading, polymer processing, sterilization [6].
Blending or copolymerization of hydrophlic compounds/polymers/blocks
was shown to produce an increase in degradation rate due to an enhancement
in water uptake [7]. Other authors have not found such a correlation between
hydrophilicity and degradation [8]. The shape or the size of the samples was
shown to influence degradation, with larger particles degrading faster than
smaller ones due to an enhancement in autocatalytic effect [9], while in other
works no evidence was found for internal catalysis [10].
Degradation kinetics was also shown to be highly dependent upon the
MW of the polymer. An increase in MW resulted in a decrease in the degra-
dation rate [11], while other authors found an opposite relationship between
degradation and MW, with higher degradation rate for high MW polymer
[12]. A higher crystallinity was indicated as a reason for the decrease in degra-
dation, because degradation rate of amorphous regions is higher than that
of crystalline regions. Other works found that samples with initial higher
crystallinity degraded faster due to the formation of a highly microporous
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structure [6].
Porosity is another factor that was found to influence degradation, with
more porous sponges degrading faster than less porous films, due to a higher
surface area in the former case [13]. In many degradation studies, no attempts
were made to determine the degradation kinetics. Thus, it is not surprising
to find differences between degradation profiles: MW variation was found
to follow an exponential decay [14], while other authors presented a linear
variation [15].
Careful consideration of processing method is necessary when comparing
results from various works, because the physical properties of the material
have a huge influence on degradation kinetics. Moreover, during degradation,
several material properties change simultaneously, which makes the assess-
ment of factor influence on degradation kinetics difficult. Thus, in this work,
various constructs based on PCL and poly(oxyethylene-b-oxypropylene-b-
oxyethylene) were prepared using different processing techniques (solvent-
casting, melt compression, SCF processing and electrospinning) so that sam-
ples of specified morphology and composition were obtained. Moreover, two
MW of PCL were used as well as drug incorporation in some of the con-
structs. This approach allowed the assessment of the processing method,
polymer MW and drug presence influence on degradation profile.
2. Materials and methods
2.1. Construct preparation
Poly(ε-caprolactone) of two MW (65000 g/mol, PCL and 15000 g/mol,
PCL10 from Sigma-Aldrich) and poly(oxyethylene-b-oxypropylene-b-oxyethylene)
or Lutrol F 127 (9000-14000 g/mol, 70 % by weight of polyoxyethylene, Lu
from BASF) and dorzolamide hydrochloride (Chemos GmbH) were used to
prepare drug-loaded disks (33.3 % w/w theoretical dorzolamide loading) and
control disks (no drug) by melt compression as already described [16]. The
ratio of polymers in the blends was : 0/100, 25/75, 50/50 % (w/w) Lu/PCL.
The same polymer and the same ratios were used to prepare films (by solvent-
casting), fibers (by electrospinning) and sponges (by supercritical fluid pro-
cessing, SCF) as previously reported [17, 18]. In Table 1, an overview of
the samples is presented. The dimensions of the constructs are presented in
Table 2. The samples were used as such in degradation experiments.
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Processing method Sample type Drug present Composition (w/w, Lu/PCL)
Solvent-casting Films
no 0/100
no 25/75
no 50/50
Melt compression Disks
no 0/100
no 25/75
no 50/50
yes 0/100
yes 25/75
yes 50/50
Electrospinning Fibers
no 0/100
no 25/75
no 50/50
Supercritical fluids Sponges
no 0/100
no 25/75
no 50/50
Table 1: Sample description
Sample Film Fiber Disk Sponge
Length (mm) 10 10 - 5
Width (mm) 10 10 - 5
Diameter (mm) - - 5 -
Thickness (mm) 0.5 0.2 1 6
Volume (mm3) 50 20 19.6 150
Surface area (mm2) 220 208 55 170
Average weight (mg) 15 13 4 11
Surface/weight ratio (mm2/mg) 14.7 16.0 13.7 15.5
Table 2: Sample dimensions used in the degradation experiment
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2.2. Crystallinity determination
The relative crystallinity of the constructs was determined by differential
scanning calorimetry (DSC, equipment Q100 from TA Instruments, 4-5 mg
of sample, hermetic pans, temperature ramp: 10 ◦C/min, temperature range:
25 to 350◦C, nitrogen flow rate: 100 mL/min) and calculated as previously
described [17, 19], considering the melting enthalpy of 100 % crystalline CL
(∆Hf,100%PCL=142 J/g) and 100 % crystalline Lu (∆Hf,100%Lu=181 J/g).
2.3. Morphology
The morphology of the constructs was examined using scanning electron
microscopy (SEM, equipment JSM 5310 from Jeol, copper coating) as previ-
ously described [17].
2.4. Molecular weight determination
The extent of hydrolytic degradation was evaluated by determining the
change of MW in time. Samples were immersed in 4 mL PBS with 0.001
% sodium azide, at 37◦C. The changes in the MW and polydispersity index
(PI) were measured by size exclusion chromatography (SEC), using chloro-
form as mobile phase (1 ml/min, 30 ◦C) and a PLgel MIXED-C column
(300 mm×7.5 mm, 5 µm, Varian). PL-EMD 960 (Polymer Laboratories)
evaporative light scattering detector was used to acquire the data. Univer-
sal calibration was performed using polystyrene (PS) standards and Mark-
Houwink parameters kPCL=1.09 ×10
−3 dl/g, αPCL=0.60, kPS=1.25 ×10
−4
dl/g, αPS=0.71. Peak integration was performed using Clarity chromatog-
raphy software (DataApex).
2.5. Statistics
All values are presented as mean and standard error of the mean (SEM).
Experiments were performed in triplicates. Statistical analysis (linear regres-
sion, independent two-tailed T test, one-way ANOVA and Tukey HSD test)
was done using OpenOffice.org Calc 3.2 and OOoStat Statistics Macro 0.5.
The results were considered statistically significant when p ≤ 0.05.
3. Results and discussion
The effect of processing method on construct degradation was assessed
by recording the change in morphology, crystallinity and MW. The sur-
face/weight ratio of the sample was kept constant (Table 2) so that material
5
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differences influence on degradation rate is evaluated without interference
from sample geometry.
3.1. Morphology
In this section, images showing the morphology of the non-degraded and
degraded constructs are presented. Initially, the films present large pores
(Fig. 1(a)) or fine grooves (Fig. 1(c)) due to solvent evaporation. Fine
grooves are formed for blends instead of pores probably because of phase sep-
aration after solvent casting. PCL chains can not aggregate intra-molecularly
because of the presence of Lu and as such the solvent can easily exit the poly-
mer phase without producing large pores. With aging, spherulites (that are
composed of lamellae spreading from nuclei) separated by large pores (≥ 10
µm) are formed due to polymer re-crystallization in PCL films (Fig. 1(b)) or
pores (∼ 1 µm) obtained due to Lu leaching are formed in blend films (Fig.
1(d)).
(a) (b)
(c) (d)
Figure 1: Films a) PCL as prepared, b) PCL degraded during 12 months, c) 50/50 Lu/PCL
as prepared, d) 50/50 Lu/PCL degraded during 12 months
With aging, the fibers lost their structural integrity: large diameters fibers
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(a) (b)
(c) (d)
Figure 2: Fibers a) PCL as prepared, b) PCL degraded during 12 months, c) 50/50
Lu/PCL as prepared, d) 50/50 Lu/PCL degraded during 12 months
collapsed and small diameter fibers “glued” on the larger ones in PCL samples
(Fig. 2(b)), while for blend samples, the fiber mat was almost transformed
into a film, with fine grooves showing the position of the initial fibers (Fig.
2(d)).
With SCF processing (supercritical carbon dioxide), in the depressuriza-
tion step, carbon dioxide passes from the supercritical to the gas state and
exits the polymer matrix, creating pores (Fig. 3(c)). Due to the fact that
the SCF decreases the melting temperature of PCL, this sample melts during
SCF processing and solidifies at depressurization. Thus, PCL sample shows
a slightly different morphology than blend samples, with smaller pores (Fig.
3(a)). During degradation, all the samples preserve their initial morphology
(Fig. 3(b) and fig. 3(d)).
In Fig. 4(a), circular structures can be observed probably corresponding
to spherulites. The drug-loaded disks present a rougher morphology due
to drug crystallization and phase separation from the polymer phase (Fig.
4(c) and Fig. 4(e)). With aging, the morphology of PCL disk without drug
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(a) (b)
(c) (d)
Figure 3: Sponges a) PCL as prepared, b) PCL degraded during 12 months, c) 50/50
Lu/PCL as prepared, d) 50/50 Lu/PCL degraded during 12 months
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does not change much with the exception of the appearance of some pores
(Fig. 4(b)). On the other hand, the surface of drug-loaded shows significant
modification: a filament-like structure composed of “channels” created by
drug elution and Lu leaching is shown by PCL (Fig. 4(d)) and blend disks
(Fig. 4(f)), while PCL10 disks present various pores, cracks and spherulitic
structures (Fig. 4(h)).
3.2. Evolution of crystallinity degree during degradation
Table 3 presents the evolution of crystallinity degree and of Tm during
degradation. For semi-crystalline polymers, crystallinity can change during
processing and/or during degradation. Usually, during degradation, there
is an increase in crystallinity due to mainly two mechanisms: on one hand,
solvent-induced crystallization of non-degraded polymer (water uptake al-
lows polymer chain rearrangement and subsequent crystallization) and, on
the other hand, crystallization of degraded fragments (oligomers) trapped
in the non-degraded polymer bulk. Thus, an increase in crystallinity is ex-
pected during degradation. This trend is, in general, observed for all PCL
samples regardless of the processing method. Interestingly, fiber blends sam-
ples showed a decrease in crystallinity with ageing (22% decrease for 50/50
Lu/PCL and 18% decrease for 25/75 Lu/PCL). This behaviour might be
related with the presence in the blend of a water-soluble polymer. Lu disso-
lution produces a decrease in crystallinity because it can cause the fragmen-
tation and erosion of non-degraded crystalline regions [7].
PCL films presented the lowest initial crystallinity, while fibers and sponges
showed the highest initial crystallinity from all the constructs. In electro-
spinning, polymer chain alignment takes place during the stretching of the
polymer solution jet in a similar fashion to crystallinity increase after fiber
drawing. On the other hand, sponges are highly crystalline due to SCF-
solvent induced crystallization during processing, since SCF swells and plas-
ticizes polymers [21]. We will discuss how the crystallinity will influence
degradation rate in section 3.3.
Table 4 presents the change in crystallinity degree for samples with dif-
ferent MW and for samples loaded with drug. Low MW disks showed higher
initial crystallinity than PCL disks as shorter PCL chains are expected to
crystallize in a higher proportion than longer PCL chains during processing.
The presence of the drug caused a decrease in initial crystallinity due to
crystallization restriction of the polymer.
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(a) (b)
(c) (d)
(e) (f)
(g) (h)
Figure 4: Disks a) PCL as prepared, b) PCL degraded during 12 months, c) PCL+drug as
prepared, d) PCL+drug degraded during 12 months, e) 50/50 Lu/PCL+drug as prepared,
f) 50/50 Lu/PCL+drug degraded during 12 months, g) PCL10+drug as prepared, h)
PCL10+drug degraded during 12 months 10
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Relative degree of crystallinity (%)
Time (months) Disks Films Fibers Sponges
0 50.26 (0.33) 41.95 (0.60) 49.76 (2.87) 52.28 (1.28)
6 47.5 (0.35) 54.79 50.58 (2.23) 51.88
18 53.2 52.11 (2.69) 51.77 (0.54) 56.08
30 na 58.51 52.76 (1.57) na
Melting temperature (◦C)
Time (months) Disks Films Fibers Sponges
0 61.26 (0.31) 57.09 (0.19) 60.06 (0.29) 63.25 (0.13)
6 63.79 (0.00) 63.73 62.27 (0.12) 65.45
18 65.77 66.41 (0.63) 63.05 (0.24) 66.59
30 na 65.87 63.77 (0.11) na
Table 3: Relative degree of crystallinity and melting temperature evolution for PCL sam-
ples (40 kDa, no drug)
There is a higher increase in crystallinity for high MW samples (40% aver-
age increase) than for low MW samples (31% average increase). The sample
without drug showed only a modest increase in crystallinity (6% increase).
The highest increase in crystallinity was presented by 50/50 Lu/PCL disk
with drug (51% increase). Lu and drug elution produce high porosity in
the sample which enhances water uptake and subsequently polymer plasti-
cization that will cause chain rearrangement and crystallinity increase over
time.
Tm also increased during the period of study suggesting that crystallite
growth and preferential hydrolysis takes place in the amorphous regions.
Usually, when hydrolysis occurs in crystalline regions, Tm decreases because
the crystallites are being destroyed. Only after 25 months, Tm does not
increase anymore or starts decreasing, suggesting that only now hydrolysis
extends to crystalline regions in agreement to previous works [20].
3.3. Evolution of molecular weight during degradation
The hydrolytic degradation mechanisms of PCL is a random chain scis-
sion process. Polymer degradation is a complex process composed of several
simultaneous physical (water uptake, swelling, dissolution, crystallization,
stress cracking) and chemical phenomena (thermolysis, oxidation, hydroly-
11
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40 kDa 10 kDa
Lu/PCL 0/100 25/75 50/50 0/100 0/100 25/75 50/50
Drug yes yes yes no yes yes yes
Time
(months)
Relative degree of crystallinity (%)
0 33.55
(0.85)
35.43
(2.84)
31.42
(0.72)
50.26
(0.33)
40.06
(0.15)
38.17
(2.33)
38.77
(1.53)
6 39.81 46.77 45.69 47.5
(0.35)
55.16
(1.52)
54.44
(1.13)
50.61
(0.94)
18 44.96
(0.01)
48.73
(1.26)
47.05
(0.91)
53.2 50.32 52.7
(0.63)
50.35
Time
(months)
Melting temperature (◦C)
0 61.54
(0.02)
60.11
(0.42)
60.14
(0.48)
61.26
(0.31)
60.67
(0.19)
61.35
(0.64)
60.55
(0.42)
6 63.82 62.95 63.77 63.79
(0.00)
62.8
(0.16)
61.67
(0.05)
61.80
(0.22)
18 66.67
(1.52)
65.15
(0.33)
65.52
(0.07)
65.77 66.41
(2.01)
63.77
(0.25)
63.03
Table 4: Relative degree of crystallinity and melting temperature evolution for disk samples
sis, photolysis). Nevertheless, for polyesters, the most important steps are
water uptake/diffusion and hydrolysis [5]. Polyesters can present surface or
bulk degradation mechanisms depending on the rate limiting step, which is
water diffusion in the first case and hydrolysis in the second case. Mass loss
or erosion occurs when water-soluble fragments that form due to hydrolysis,
are able to leach out from the polymer matrix. As hydrolysis is a random
chain cleavage process, the probability to obtain a water-soluble fragment
that is small enough to diffuse from the bulk increases as MW decreases.
In Fig. 5(a), Fig. 5(b) and Fig. 5(c) the change in weight-average MW
is presented for samples processed by different methods. It can be noted for
PCL samples, at 6 months that there are some differences in terms of MW
decrease between processing techniques: films, fibers and sponges showed a
decrease of approximately 10%, while fibers showed a smaller decrease (4%).
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The differences between samples become smaller after 18 months with 45%
decrease in MW for disk, 58% for fiber and 54% for films. This might be
explained by water uptake kinetics which is controlled by initial construct
porosity. Thus, sponges, films and disks have high initial porosity and high
water uptake relative to fibers and show faster degradation at 6 months.
PCL fibers are much more hydrophobic, which inhibits water uptake [17].
Developed porosity and subsequently reaction surface is important for the
later stages of degradation [14]. Sponges maintain their high initial porosity
during aging, while films and fibers do not. This might be the reason why
PCL fibers (20% decrease) and films (17% decrease) are less degraded than
sponges (46% decrease) at 18 months.
Blend disks show statistically significant differences in MW when com-
pared to sponges, films or fibers only at 6 and 12 months, but not at 18
months. Thus, at 18 months water content of the various constructs is ex-
pected to be similar. At 30 months, the different constructs showed similar
decrease in MW (for 50/50 Lu/PCL samples: 61% for disks, 71% for films
and 69% for fibers). When comparing the degradation curves for different
compositions of the same construct, the blends degraded faster than PCL.
This might be connected to the change in crystallinity. PCL samples showed
a slight increase in crystallinity during ageing, while blends showed a signif-
icant decrease in crystallinity in some cases.
A comparison between the degradation profile for samples of different
MW is shown in Fig. 6(a), fig. 6(b) and Fig. 6(c). The decrease in MW
is much lower for 10 kDa samples than for 40 kDa samples (for PCL, at 18
months, 8% decrease and 38% decrease, respectively). In addition, there are
no differences in terms of MW due to composition. First, 10 kDa samples
have higher initial crystallinity than 40 kDa samples and this will slow down
water uptake (1% water content after 1 month). Additionally, for a short
chain polymer, there is a higher probability to obtain water soluble fragments
at hydrolysis, that leach out, especially through a porous structure, leading to
a decrease in autocatalytic effects. These factors contributed synergistically
to the observed degradation delay.
Degradation curves of drug-loaded disks and disks without drug are shown
in Fig. 7(a) and Fig. 7(b). Drug-loaded PCL disks showed a 4% decrease
in MW, while PCL disks without drug presented a 9% decrease in MW at 6
months. At 12 and 18 months, there were no significant differences in MW
decrease between the different PCL samples. The same observation was valid
for blend disks that only showed at 6 months a higher decrease in MW for
13
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
        







	
	 
		


	 	
		

	

 


!



(a)
        







	
	 
		


	 	
		

	

 


!



(b)
        







	
	 
		


	 	
		

	

 


!



(c)
Figure 5: Weight average molecular weight of a) PCL, b) 25/75 Lu/PCL and c) 50/50
Lu/PCL constructs
samples without drug probably due to increased autocatalytic effects. The
PCL samples with drug showed a much higher increase in crystallinity and
thus degradation will be slower in these samples.
4. Conclusions
Various constructs were prepared based on PCL and Lu, such as films,
fibers, sponges and disks using different techniques such as solvent-casting,
electrospinning, supercritical fluid processing and melt-compression, respec-
tively. The influence on degradation rate of several factors (processing method,
MW, drug presence, composition) was determined.
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(c)
Figure 6: Weight average molecular weight of a) PCL, b) 25/75 Lu/PCL and c) 50/50
Lu/PCL constructs
Overall, there was an increase in crystallinity with degradation in agree-
ment with previous works. MW had an important effect on degradation rate.
The low MW disks had a degradation rate that was lower by one order of
magnitude than high MW constructs. On the other hand, the drug had little
effect on degradation with significant differences only in the initial stage (up
to 6 months).
Although there were some differences in degradation profile for samples
prepared by different processing methods up to 18 months, these differences
tended to disappear during the advanced stage (18 to 36 months). Water
uptake kinetics and polymer chain rearrangement will produce significant
changes in construct morphology, porosity and crystallinity during the initial
15
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(b)
Figure 7: Weight average molecular weight of a) PCL, b) 25/75 Lu/PCL disks
stage with direct results on degradation rates. Thus, it was shown that
processing method does not have such a significant effect on the long term
degradation of the PCL constructs.
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